These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 27223157)
21. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis. Iwamoto J; Takeda T; Sato Y Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313 [TBL] [Abstract][Full Text] [Related]
22. Recognition of women at risk for fracture and intervention with fast-acting therapies. Derman R Int J Fertil Womens Med; 2006; 51(4):183-90. PubMed ID: 17184104 [TBL] [Abstract][Full Text] [Related]
23. Ask the doctor. I've had osteoporosis for several years, and I've been taking alendronate (Fosamax) once a week. I wasn't very good at remembering to take it regularly, so my doctor recently recommended that I start on once-a-year infusions of zoledronic acid (Reclast). Will it work as well to prevent me from breaking a bone? Fabiny A Harv Womens Health Watch; 2014 Apr; 21(8):2. PubMed ID: 25097938 [No Abstract] [Full Text] [Related]
24. Bisphosphonates for osteoporosis. Vis M; Dijkmans BA; Lems WF N Engl J Med; 2011 Feb; 364(6):582-3; author reply 583-4. PubMed ID: 21306267 [No Abstract] [Full Text] [Related]
25. Sustained vertebral antifracture efficacy of oral anti-osteoporotic therapies in postmenopausal osteoporosis. Brandi ML Curr Med Res Opin; 2010 Nov; 26(11):2553-63. PubMed ID: 20858031 [TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis. Makras P; Hamdy NA; Zwinderman AH; Ballieux BE; Papapoulos SE Bone; 2009 May; 44(5):766-71. PubMed ID: 19442613 [TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate therapy for secondary osteoporosis: adult perspective. Reid IR Horm Res Paediatr; 2011; 76 Suppl 1():28-32. PubMed ID: 21778745 [TBL] [Abstract][Full Text] [Related]
28. Bisphosphonates for Postmenopausal Osteoporosis. Ensrud KE JAMA; 2021 Jan; 325(1):96. PubMed ID: 33399841 [No Abstract] [Full Text] [Related]
29. Yearly zoledronic acid in postmenopausal osteoporosis. Najib MA; Aziz I N Engl J Med; 2007 Aug; 357(7):713; author reply 714-5. PubMed ID: 17703527 [No Abstract] [Full Text] [Related]
30. Reclast approved for osteoporosis treatment in postmenopausal women. Laustsen G Nurse Pract; 2007 Dec; 32(12):12-4. PubMed ID: 18043404 [No Abstract] [Full Text] [Related]
31. [Treatment of postmenopausal osteoporosis in the general medical practice (clinical case)]. Zhdan VM; Kitura OIe; Kitura IeM; Babanina MIu; Tkachenko MV Lik Sprava; 2013 Mar; (2):85-9. PubMed ID: 24605616 [TBL] [Abstract][Full Text] [Related]
36. Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. Colón-Emeric CS JAMA; 2006 Dec; 296(24):2968-9. PubMed ID: 17190899 [No Abstract] [Full Text] [Related]
37. The treatment of postmenopausal osteoporosis. Sambrook PN N Engl J Med; 1995 Nov; 333(22):1495-6. PubMed ID: 7477151 [No Abstract] [Full Text] [Related]
38. [Evidence for positive effects of long-term bisphosphonate administration.]. Hagino H Clin Calcium; 2017; 27(2):203-211. PubMed ID: 28123122 [TBL] [Abstract][Full Text] [Related]
39. Treatments for osteoporosis - looking beyond the HORIZON. Compston J N Engl J Med; 2007 May; 356(18):1878-80. PubMed ID: 17476015 [No Abstract] [Full Text] [Related]
40. Yearly zoledronic acid in postmenopausal osteoporosis. de Nijs RN; Westgeest AA N Engl J Med; 2007 Aug; 357(7):711; author reply 714-5. PubMed ID: 17699824 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]